VRSN
66
4
KR
49
4
BSX
42
2
NWSA
42
-18
NAVI
40
2
KMX
42
2
MCO
56
3
AIV
34
4
PH
60
-2
A
37
3
FE
62
2
MDLZ
34
4
EMR
51
-2
FFIV
52
3
PNC
59
3
IRM
47
3
DG
57
7
SWKS
37
6
ECL
59
-3
TRV
42
5
VRSN
66
4
KR
49
4
BSX
42
2
NWSA
42
-18
NAVI
40
2
KMX
42
2
MCO
56
3
AIV
34
4
PH
60
-2
A
37
3
FE
62
2
MDLZ
34
4
EMR
51
-2
FFIV
52
3
PNC
59
3
IRM
47
3
DG
57
7
SWKS
37
6
ECL
59
-3
TRV
42
5
Financhill
Back

Amneal Pharmaceuticals, Inc. 10K Form

Sell
44

AMRX
Amneal Pharmaceuticals, Inc.

Last Price:
$12.48
Seasonality Move:
10.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMRX News And Ratings

See the #1 stock for the next 7 days that we like better than AMRX

AMRX Financial Statistics

Sales & Book Value

Annual Sales: $3B
Cash Flow: $84.1M
Price / Cash Flow: 17.64
Annual Sales: $-0.23
Price / Book: 5.62

Profitability

EPS (TTM): 0.22130
Net Income (TTM): $127.9M
Gross Margin: $1.1B
Return on Equity: -587.3%
Return on Assets: 3.64%

Amneal Pharmaceuticals, Inc. Earnings Forecast

Key Amneal Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 27 years for AMRX is 37.63%.
  • The Selling, General & Administrative Expenses for AMRX have been equal to 17.45% of Gross Profit Margin.
  • The Research & Development expenses have been 6.17% of Revenue.
  • The Interest Expense is 188.45% of Operating Income.
  • The Net Earning history of AMRX is 4.24% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 14 years.

Amneal Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AMRX
CUSIP: 03168L
Website: amneal.com

Debt

Debt-to-Equity Ratio: -37.98
Current Ratio: 2.17
Quick Ratio: 1.37

Price-to-Earnings

Trailing P/E Ratio: 55.25
Forward P/E Ratio: 10.42

AMRX Technical Analysis vs Fundamental Analysis

Sell
44
Amneal Pharmaceuticals, Inc. (AMRX) is a Sell

Is Amneal Pharmaceuticals, Inc. a Buy or a Sell?